Sign Up to Receive Your Personalised Learning Resources
CONFERENCE HUB
CONy 2024: Key takeaways from the 18th World Congress on Controversies in Neurology
Start Learning
The Future of SCN1A Gene-targeting Research for the Treatment of Dravet Syndrome
Foreword: touchREVIEWS in Neurology, Volume 19, Issue 2, 2023
Present and Future of Biomarkers for Accurate Diagnosis of Alzheimer’s Disease: Integrating Clinical and Biomarker Assessments for a Timely and Accurate Diagnosis
Enrique Alvarez, AAN 2023: Ublituximab for participants with relapsing multiple sclerosis
Anthony Béhin, EAN 2023: Highlights in myasthenia gravis
Stewart Tepper, AAN 2023: Significant reduction in migraine days with REN for migraine prevention: A double-blind randomized sham-controlled clinical trial
Recent Advances on the Diagnosis and Management of Seronegative Neuromyelitis Optica Spectrum Disorder
Peter Goadsby, EAN 2023: Highlights in migraine
Contemporary insights on the management of sickle cell disease: Focus on complications and recent advances in therapy
Updates in the Use of Vamorolone and Steroids in the Treatment of Duchenne Muscular Dystrophy
Sign up to view Favourites, Keep Notes and Track CME Credits
Favourites
Updates in the Use of Vamorolone and Steroids in the Treatment of Duchenne Muscular Dystrophy
View
Simon Faissner, EAN 2023: Safety and efficacy of diroximel fumarate in older patients with multiple sclerosis from the phase III EVOLVE-MS-1 study
View
Kristian Steen Frederiksen, EAN 2023: Highlights in Alzheimer’s disease and dementia
View
Optimizing the management of patients with relapsing forms of MS: An update on emerging treatment options
View
Individualizing long-term treatment and care in active MS: How are therapeutic sequencing options evolving to address unmet needs?
View
Michael Levy: Highlights from the 75th AAN Annual Meeting, 2023
View
Discovery of ketamine to treat psychiatric disorders targeting monoamine signaling: John Krystal, APA 2023
View
Current oral migraine therapy: targeting calcitonin gene-related peptide (CGRP)
View
Stewart Tepper, AAN 2023: Phase 3 ASCEND interim analysis – STS101 for the treatment of acute migraine
View
Sharing perspectives: Specific DEEs through the lens of a paediatric and an adult neurologist
View